New modifications of acetylation of the C1 inhibitor (C1-INH) have been identified, thereby explaining the association of the levels of autoantibodies against acetylated C1-INH peptides with the risk of developing SLE [53]. The gene discussed is SERPING1; the disease is systemic lupus erythematosus.